Pfizer Inc
Pharmaceutical & Health Products · Lobbying Client
Pfizer Inc's Federal Lobbying Record
Pfizer Inc's disclosed federal lobbying spend of $54.4M places it among the top-tier spenders tracked here — organizations that put real, recurring dollars behind their federal advocacy. Spending at this level usually involves a dedicated in-house team, multiple outside firms, and steady quarterly filings rather than one-off campaigns tied to a single bill.
Across the 5-year window from 2020 to 2024, Pfizer Inc's annual disclosed lobbying spend has declined modestly — from $10.9M in 2020 to $10.1M in 2024, a change of -8%. Step-changes of this size often coincide with major bills moving through Congress, regulatory rulemakings affecting the organization's industry, or a leadership change in the relevant committee.
Pfizer Inc's disclosed lobbying covers 8 general issue areas — a moderate footprint. Filers in this range tend to engage on a coherent cluster of related topics rather than spreading effort across the federal agenda.
8 of 36 lobbyists reported by Pfizer Inc (22%) disclose prior federal government service — a small minority of the named bench.
Among the named bench, lobbyists with disclosed prior federal service include Jennifer A. Williams (Former Legislative Director, U.S. House of Representatives); Kevin D. Hill (Former Legislative Assistant, U.S. Senate); Charles D. Martinez (Former Commissioner, FCC). The covered-position field on LDA cover sheets captures executive-branch and senior congressional roles held within the prior two years.
Within the Pharmaceutical & Health Products sector, Pfizer Inc ranks #2 of 34 tracked organizations by disclosed lobbying spend. The sector leader is Pharmaceutical Research & Manufacturers of America at $135.8M; the sector average is $16.7M. Pfizer Inc's $54.4M sits 226% above the sector average.
Pfizer Inc's LobbySpend Influence Score of 64/100 (grade B) reflects significant federal lobbying reach. The score blends disclosed total spend, issue breadth, and revolving-door connections — lobbyists with prior federal government service. A B-grade typically means the organization is well above average on at least two of those three signals, with sustained activity over multiple years rather than a one-off spike.
Every figure above is sourced from Senate lobbying disclosure filings submitted under the Lobbying Disclosure Act of 1995. Per-issue dollar splits and covered-position flags are filer-reported and may be amended after initial submission.
Track Pfizer Inc's lobbying filings
Subscribe for LobbySpend updates by email. No spam, unsubscribe anytime.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2024 Oct-Dec | Subject Matter | PHAHCR | 3 | $2.0M |
| 2024 Jul-Sep | Hogan Lovells | MEDHCRTRD+2 | 1 | $2.8M |
| 2024 Apr-Jun | K&L Gates | HCRGOV | 2 | $2.4M |
| 2024 Jan-Mar | K&L Gates | GOVHCRBUD+1 | 1 | $2.2M |
| 2023 Oct-Dec | Van Scoyoc Associates | PHABUD | 1 | $2.5M |
| 2023 Jul-Sep | Podesta Group | HCRTAXPHA | 2 | $2.9M |
| 2023 Apr-Jun | Williams & Jensen | GOVPHA | 2 | $2.6M |
| 2023 Jan-Mar | Arnold & Porter | TRDTAXCPT | 4 | $3.0M |
Pfizer Inc Lobbying FAQ
Pfizer Inc has spent $54.4M on federal lobbying across 8 policy areas. This includes spending on registered lobbyists and direct government contacts.
Pfizer Inc lobbies on 8 policy issues, including Health Issues, Pharmacy, Medical/Disease Research, Copyright/Patent/Trademark. These disclosures are filed quarterly with the Senate Office of Public Records.
Pfizer Inc has an Influence Score of 64/100 (Grade B). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).
Pfizer Inc employs 36 registered lobbyists, of whom 8 have revolving door connections, meaning they previously held government positions before becoming lobbyists.
Pfizer Inc has contacted 11 government entities as part of their lobbying activities, including Federal Energy Regulatory Commission, Dept of Education, U.S. Senate.
Explore Other Lobbying Organizations
$387.8M lobbying spend · Trade Association · Influence Score B
$348.2M lobbying spend · Real Estate · Influence Score B
$135.8M lobbying spend · Pharmaceutical & Health Products · Influence Score B
$128.0M lobbying spend · Healthcare · Influence Score B
Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.